Literature DB >> 16410582

Gastro-oesophageal reflux disease.

Mark Fox1, Ian Forgacs.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16410582      PMCID： PMC1326932          DOI： 10.1136/bmj.332.7533.88

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Authors:  M F Vela; L Camacho-Lobato; R Srinivasan; R Tutuian; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Managing Barrett's oesophagus.

Authors:  Stuart Jon Spechler
Journal:  BMJ       Date:  2003-04-26

Review 3.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

Authors:  E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

6.  Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers.

Authors:  N J Trudgill; S A Riley
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

7.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

Authors:  S J Spechler; E Lee; D Ahnen; R K Goyal; I Hirano; F Ramirez; J P Raufman; R Sampliner; T Schnell; S Sontag; Z R Vlahcevic; R Young; W Williford
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

8.  Correlation of oesophageal acid exposure with Barrett's oesophagus length.

Authors:  R Fass; R W Hell; H S Garewal; P Martinez; G Pulliam; C Wendel; R E Sampliner
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

Review 10.  Gastroesophageal reflux disease--should we adopt a new conceptual framework?

Authors:  Ronnie Fass; Joshua J Ofman
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864
View more
  17 in total

1.  Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution.

Authors:  Stéphane Mouly; Agnès Charlemagne; Philippe Lejeunne; Francis Fagnani
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

2.  Gastro-oesophageal reflux disease: surgery is an alternative.

Authors:  David Mahon; Michael Rhodes
Journal:  BMJ       Date:  2006-01-28

3.  Gastro-oesophageal reflux disease: posture is important.

Authors:  Norman K Gibbon
Journal:  BMJ       Date:  2006-01-28

4.  The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma.

Authors:  K F Alhabib; S Vedal; P Champion; J M Fitzgerald
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

5.  Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Yi-Chia Lee; Chi-Yang Chang; Ching-Tai Lee; Jaw-Town Lin
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

6.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Transcutaneous cervical esophagus ultrasound in adults: relation with ambulatory 24-h pH-monitoring and esophageal manometry.

Authors:  Sabite Kacar; Selma Uysal; Sedef Kuran; Ulku Dagli; Yasemin Ozin; Erdem Karabulut; Nurgul Sasmaz
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

8.  Aerophagia and gastroesophageal reflux disease in patients using continuous positive airway pressure: a preliminary observation.

Authors:  Nathaniel F Watson; Sue K Mystkowski
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

9.  The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study.

Authors:  Werner Schwizer; Dieter Menne; Kurt Schütze; Michael Vieth; Reiner Goergens; Peter Malfertheiner; Andreas Leodolter; Michael Fried; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.